Oligonucleotides containing 2′-O-modified purines
AssigneeIsis Pharmaceuticals, Inc.
InventorsPhillip Dan Cook, Daniel Peter Claude McGee, Charles John Guinosso
Life of this patent
Estimating the term…
Loading patent…
AssigneeIsis Pharmaceuticals, Inc.
InventorsPhillip Dan Cook, Daniel Peter Claude McGee, Charles John Guinosso
Estimating the term…
Compounds are provided containing purine nucleotides that bear moieties X at the 2′ position thereof wherein X is R1—(R2)n; R1 is C3-C20 alkyl, C4-C20 alkenyl or C2-C20 alkynyl; R2 is halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, amino, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, or a group that enhances the pharmacokinetic properties of oligonucleotides; and n is an integer from 0 to about 6. Such compounds are useful for modulating the synthesis of proteins.
A compound having the structure:
A compound having the structure:
The compound of claim wherein R1 is C2-C20 alkynyl and n is 1 to 6.
A compound having the structure:
A compound having the structure:
Dependencies are inferred from the claim text.